Comment on: "Willingness to Pay for a COVID-19 Vaccine"
- PMID: 33973148
- PMCID: PMC8110430
- DOI: 10.1007/s40258-021-00656-2
Comment on: "Willingness to Pay for a COVID-19 Vaccine"
Conflict of interest statement
Not applicable.
Figures

Comment in
-
Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".Appl Health Econ Health Policy. 2021 Jul;19(4):623-624. doi: 10.1007/s40258-021-00657-1. Epub 2021 May 11. Appl Health Econ Health Policy. 2021. PMID: 33973149 Free PMC article. No abstract available.
Comment on
-
Willingness to Pay for a COVID-19 Vaccine.Appl Health Econ Health Policy. 2021 May;19(3):343-351. doi: 10.1007/s40258-021-00644-6. Epub 2021 Feb 23. Appl Health Econ Health Policy. 2021. PMID: 33619688 Free PMC article.
Similar articles
-
Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".Appl Health Econ Health Policy. 2021 Jul;19(4):623-624. doi: 10.1007/s40258-021-00657-1. Epub 2021 May 11. Appl Health Econ Health Policy. 2021. PMID: 33973149 Free PMC article. No abstract available.
-
Chinese consumers' willingness to get a COVID-19 vaccine and willingness to pay for it.PLoS One. 2021 May 4;16(5):e0250112. doi: 10.1371/journal.pone.0250112. eCollection 2021. PLoS One. 2021. PMID: 33945544 Free PMC article.
-
The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated.Eur J Intern Med. 2021 May;87:106-108. doi: 10.1016/j.ejim.2021.03.015. Epub 2021 Mar 19. Eur J Intern Med. 2021. PMID: 33810941 Free PMC article. No abstract available.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.Int Arch Allergy Immunol. 2020;181(8):624-628. doi: 10.1159/000509368. Epub 2020 Jun 16. Int Arch Allergy Immunol. 2020. PMID: 32544911 Free PMC article. Review.
Cited by
-
Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".Appl Health Econ Health Policy. 2021 Jul;19(4):623-624. doi: 10.1007/s40258-021-00657-1. Epub 2021 May 11. Appl Health Econ Health Policy. 2021. PMID: 33973149 Free PMC article. No abstract available.
-
Prevalence, Knowledge and Potential Determinants of COVID-19 Vaccine Acceptability Among University Students in the United Arab Emirates: Findings and Implications.J Multidiscip Healthc. 2022 Jan 11;15:81-92. doi: 10.2147/JMDH.S341700. eCollection 2022. J Multidiscip Healthc. 2022. PMID: 35046663 Free PMC article.
-
Parents' willingness to pay for their children's COVID-19 vaccine in Taiwan, China: A cross-sectional study.Hum Vaccin Immunother. 2023 Dec 31;19(1):2168936. doi: 10.1080/21645515.2023.2168936. Epub 2023 Jan 22. Hum Vaccin Immunother. 2023. PMID: 36683206 Free PMC article.
-
Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana.BMC Public Health. 2022 Jun 30;22(1):1273. doi: 10.1186/s12889-022-13602-1. BMC Public Health. 2022. PMID: 35773637 Free PMC article.
References
-
- Petter E, Mor O, Zuckerman N, et al. Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2. medRxiv. 2021 doi: 10.1101/2021.02.08.21251329. - DOI
-
- Why a pioneering plan to distribute COVID vaccines equitably must succeed. Nature 2021; 589:170–170. doi:10.1038/d41586-021-00044-9 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical